Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-25-004774
Filing Date
2025-02-11
Accepted
2025-02-11 07:35:37
Documents
11
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 6-K form6-kxfebruary112025.htm 6-K 13416
2 EX-99.1 organigramholdingsinc-2mda.htm EX-99.1 679067
3 EX-99.2 organigramholdingsinc-1fsx.htm EX-99.2 586407
4 EX-99.3 ceocertification-2025q1.htm EX-99.3 16812
5 EX-99.4 cfocertification-2025q1.htm EX-99.4 16551
6 EX-99.5 organigramholdingsinc-3prx.htm EX-99.5 164372
7 a2023_q1xcoversxbacka.jpg GRAPHIC 163902
8 a2023_q1xcoversxbackb.jpg GRAPHIC 163902
9 a2025_q1xcoversxfinancialsa.jpg GRAPHIC 2149996
10 a2025_q1xcoversxmda.jpg GRAPHIC 2147326
11 blueleafsa.gif GRAPHIC 559128
  Complete submission text file 0001628280-25-004774.txt   8489164
Mailing Address 35A ENGLISH DR. MONCTON A3 E1E 3X3
Business Address 35A ENGLISH DR. MONCTON A3 E1E 3X3 506-384-1571
ORGANIGRAM HOLDINGS INC. (Filer) CIK: 0001620737 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-38885 | Film No.: 25607690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)